Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000126860 | SCV000170389 | benign | not specified | 2013-09-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000126860 | SCV000313157 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000608965 | SCV000745036 | benign | Spastic ataxia 4 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000608965 | SCV002014280 | benign | Spastic ataxia 4 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002055684 | SCV002427631 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV002055684 | SCV005317023 | benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000608965 | SCV000732938 | benign | Spastic ataxia 4 | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000126860 | SCV001956270 | benign | not specified | no assertion criteria provided | clinical testing |